Skip to content
Life Sciences Series B Founded 2006

Rebus Biosystems

Rebus Biosystems develops an imaging system for analyzing genes in single cells using its patented Synthetic Aperture Optics system for multiple gene expression analysis. Its Rebus Esper platform integrates imaging, fluidics, chemistry, and bioinformatics to deliver spatial omics data. Founded in 2006 in Santa Clara, United States, the company has raised $20.0M in Series B funding from investors including Illumina…

📍 Santa Clara, United States · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeries B
Amount$20M
Date19 November 2020
Total raised$20M
Team size8

About

Rebus Biosystems develops an imaging system for analyzing genes in single cells using its patented Synthetic Aperture Optics system for multiple gene expression analysis. Its Rebus Esper platform integrates imaging, fluidics, chemistry, and bioinformatics to deliver spatial omics data. Founded in 2006 in Santa Clara, United States, the company has raised $20.0M in Series B funding from investors including Illumina Ventures and HHS. Developer of an imaging system for the analysis of genes in a single cell. The company’s patented technology includes a Synthetic Aperture Optics system used for the analysis of multiple gene expressions in single cells. This technology can be used for imaging full tissue sections using laser beams at subcellular resolution.

Business model

Genomics > Enabling Technologies > Instrument Systems > Single Cell Genomics,

Life Sciences Platforms and Tools > Instruments > Cell Biology > Cell Analysis > Single Cell Multi Omics

Team background

College Wise > Massachusetts Institute of Technology, University of California (Berkeley)

Institutional investors

Illumina Ventures Lifecore Ncore Ventures Ray Medical Time Polio Asset Management Seegene Technologies CTK Investment LabGenomics HHS

Latest coverage

No articles yet.

Raising like Rebus Biosystems?

Analyze your pitch deck before your next raise.

Analyze My Deck →